Why Black Diamond Therapeutics Inc (NASDAQ:BDTX) Stock down -12.21% in Last Week?
Piper Sandler raised the price target for the Black Diamond Therapeutics Inc (NASDAQ:BDTX) stock to “an Overweight”. The rating was released on July 14, 2023, according to finviz. We previously noted in another research note published on June 30, 2023 by Stifel that upgraded the stock from a Hold to a Buy with a price […]
The growth of Black Diamond Therapeutics Inc (BDTX) Stock is expected to continue
Piper Sandler raised the price target for the Black Diamond Therapeutics Inc (NASDAQ:BDTX) stock to “an Overweight”. The rating was released on July 14, 2023, according to finviz. We previously noted in another research note published on June 30, 2023 by Stifel that upgraded the stock from a Hold to a Buy with a price […]
What are the chances of Black Diamond Therapeutics Inc (BDTX) Stock turning the corner?
Piper Sandler raised the price target for the Black Diamond Therapeutics Inc (NASDAQ:BDTX) stock to “an Overweight”. The rating was released on July 14, 2023, according to finviz. We previously noted in another research note published on June 30, 2023 by Stifel that upgraded the stock from a Hold to a Buy with a price […]
Black Diamond Therapeutics Inc (BDTX) Stock Is Looking Attractive
Piper Sandler raised the price target for the Black Diamond Therapeutics Inc (NASDAQ:BDTX) stock to “an Overweight”. The rating was released on July 14, 2023, according to finviz. We previously noted in another research note published on June 30, 2023 by Stifel that upgraded the stock from a Hold to a Buy with a price […]
The performance of Black Diamond Therapeutics Inc (BDTX) Stock has improved
Piper Sandler raised the price target for the Black Diamond Therapeutics Inc (NASDAQ:BDTX) stock to “an Overweight”. The rating was released on July 14, 2023, according to finviz. We previously noted in another research note published on June 30, 2023 by Stifel that upgraded the stock from a Hold to a Buy with a price […]
The Black Diamond Therapeutics Inc (BDTX) Stock expansion path ahead
Piper Sandler raised the price target for the Black Diamond Therapeutics Inc (NASDAQ:BDTX) stock to “an Overweight”. The rating was released on July 14, 2023, according to finviz. We previously noted in another research note published on June 30, 2023 by Stifel that upgraded the stock from a Hold to a Buy with a price […]
